APA

Berchtold L. A., Miani M., Diep T. A., Madsen A. N., Cigliola V., Colli M., Krivokapic J. M., Pociot F., Eizirik D. L., Meda P., Holst B., Billestrup N. & Størling J. (20171121). Pannexin-2-deficiency sensitizes pancreatic β-cells to cytokine-induced apoptosis in vitro and impairs glucose tolerance in vivo. : Molecular and cellular endocrinology.

Chicago

Berchtold Lukas A, Miani Michela, Diep Thi A, Madsen Andreas N, Cigliola Valentina, Colli Maikel, Krivokapic Jelena M, Pociot Flemming, Eizirik Decio L, Meda Paolo, Holst Birgitte, Billestrup Nils and Størling Joachim. 20171121. Pannexin-2-deficiency sensitizes pancreatic β-cells to cytokine-induced apoptosis in vitro and impairs glucose tolerance in vivo. : Molecular and cellular endocrinology.

Harvard

Berchtold L. A., Miani M., Diep T. A., Madsen A. N., Cigliola V., Colli M., Krivokapic J. M., Pociot F., Eizirik D. L., Meda P., Holst B., Billestrup N. and Størling J. (20171121). Pannexin-2-deficiency sensitizes pancreatic β-cells to cytokine-induced apoptosis in vitro and impairs glucose tolerance in vivo. : Molecular and cellular endocrinology.

MLA

Berchtold Lukas A, Miani Michela, Diep Thi A, Madsen Andreas N, Cigliola Valentina, Colli Maikel, Krivokapic Jelena M, Pociot Flemming, Eizirik Decio L, Meda Paolo, Holst Birgitte, Billestrup Nils and Størling Joachim. Pannexin-2-deficiency sensitizes pancreatic β-cells to cytokine-induced apoptosis in vitro and impairs glucose tolerance in vivo. : Molecular and cellular endocrinology. 20171121.